Atreca, Inc., Licenses Transformational “Immune Repertoire Capture” Technology from Stanford University
08:30 EDT 14 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Atreca, Inc., today announced that Stanford University has granted the
company an exclusive license to transformational technology for
harnessing the power of the immune response to generate a wide range of
medical products.
...
Other Sources for this Article
Company:
Atreca, Inc.
Paulette Dillon
Chief Business
Officer
1-650-595-2661
info@atreca.com
or
Media:
Michele
Parisi
1-925-429-1850
mparisi@biocommnetwork.com
More From BioPortfolio on "Atreca, Inc., Licenses Transformational “Immune Repertoire Capture” Technology from Stanford University"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
